A genetic polymorphism of the peroxisome proliferator-activated receptor γ gene influences plasma leptin levels in obese humans

Human Molecular Genetics

Volumn 7, Issue 3, 1998, Pages 435-440

  Meirhaeghe, Aline ^a   Fajas, Lluis ^a   Helbecque, Nicole ^a   Cottel, Dominique ^a   Lebel, Pascal ^a   Dallongeville, Jean ^a   Deeb, Samir ^b   Auwerx, Johan ^a   Amouyel, Philippe ^a,c  

^a INSTITUT PASTEUR DE LILLE   (France)

^b UNIVERSITY OF WASHINGTON SCHOOL OF MEDICINE   (United States)

^c UNIV LILLE   (France)

Author keywords

[No Author keywords available]

Indexed keywords

LEPTIN; PEROXISOME PROLIFERATOR; TRANSCRIPTION FACTOR;

ADIPOCYTE; ARTICLE; BODY MASS; BODY WEIGHT; FEMALE; FRANCE; GENE ACTIVATION; GENETIC POLYMORPHISM; GLUCOSE METABOLISM; HUMAN; HUMAN CELL; LIPID METABOLISM; MAJOR CLINICAL STUDY; MALE; NUCLEIC ACID BASE SUBSTITUTION; OBESITY; PEROXISOME; PHENOTYPE; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; RECEPTOR GENE;

ADULT; AGE FACTORS; ALLELES; BLOOD PRESSURE; BODY MASS INDEX; BODY WEIGHT; EXONS; FEMALE; FRANCE; HUMANS; LEPTIN; MALE; MIDDLE AGED; NUCLEAR PROTEINS; OBESITY; PATIENT SELECTION; PHENOTYPE; POINT MUTATION; POLYMORPHISM, GENETIC; PROTEINS; RECEPTORS, CYTOPLASMIC AND NUCLEAR; REFERENCE VALUES; REGRESSION ANALYSIS; TRANSCRIPTION FACTORS;

EID: 0031912333     PISSN: 09646906     EISSN: None     Source Type: Journal    
DOI: 10.1093/hmg/7.3.435     Document Type: Article

References (31)

1. Bouchard,C., Pérusse,L., Leblanc,C., Tremblay,A. and Theriault,G. (1988) Inheritance of the amount and distribution of human body fat. Int. J. Obesity, 12, 205-215.
2. Tontonoz,P., Hu,E. and Spiegelman,B.M. (1994) Stimulation of adipogenesis in fibroblasts by PPARγ2, a lipid-activated transcription factor. Cell, 79, 1147-1156.
3. 2 is a ligand for the adipocyte determination factor PPARγ. Cell, 83, 803-812.
4. 2 metabolite binds peroxisome proliferator-activated receptor y and promotes adipocyte differentiation. Cell, 83, 813-819.
5. Auwerx,J., Martin,G., Guerre-Millo,G. and Staels,B. (1996) Transcription, adipocyte differentiation, and obesity. J, Mol, Med., 74, 347-352.
6. Spiegelman,B.M. and Flier,J.S. (1996) Adipogenesis and obesity: rounding out the big picture. Cell, 87, 377-389.
7. Schoonjans,K., Peinado-Onsurbe,J., Lefebvre,A.M., Heyman,R.A., Briggs,M., Deeb,S., Staels,B. and Auwerx,J. (1996) PPARα and PPARγ activators direct a tissue-specific transcriptional response via PPRE in the lipoprotein lipase gene. EMBO J., 15, 5336-5348.
8. Tontonoz,P., Hu.E., Graves,R.A., Budavari,A.I. and Spiegelman,B.M. (1994) mPPARγ2: tissue-specific regulator of an adipocyte enhancer. Genes Dev., 8, 1224-1234.
9. Tontonoz,P., Hu,E., Devine,J., Beale,E.G. and Spiegelman,B.M. (1995) PPARγ2 regulates adipose expression of the phosphoenolpyruvate carboxykinase gene. Mol. Cell. Biol., 15, 351-357.
10. Schoonjans,K., Watanabe,M., Suzuki,H., Mahfoudi,A., Krey,G., Wahli,W., Grimaldi,P., Staels,B., Yamamoto,T. and Auwerx,J. (1995) Induction of the acyl-coenzyme A synthetase gene by fibrates and fatty acids is mediated by a peroxisome proliferator response element in the C promoter. J. Biol. Chem., 270, 19269-19276.
11. Kallen,C.B. and Lazar,M.A. (1996) Antidiabetic thiazolidinediones inhibit leptin (ob) gene expression in 3T3-L1 adipocytes. Proc. Natl. Acad. Sci. USA, 93, 5793-5796.
12. De Vos,P., Lefebvre,A.M., Miller,S.G., Guerre-Millo,M., Wong,K., Saladin,R., Hamann,L.G., Staels,B., Briggs,M.R. and Auwerx,J. (1996) Thiazolidinediones repress oh gene expression via activation of PPARγ. J. Clin. Invest., 98, 1004-1009.
13. Zhang,B., Graziano,M.P., Doebber,T.W., Leibowitz,M.D., White-Carrington,S., Szalkowski,D.M., Hey,P.T., Wu,M., Cullinan,C.A., Bailey,P., Collmann,B., Frederich,R., Flier,J.S., Strader,C.D. and Smith,R.G. (1996) Down-regulation of the expression of the obese gene by antidiabetic thiazolidinediones in Zucker diabetic fatty rats and db/db mice. J. Biol. Chem., 271, 9455-9459.
14. Hollenberg,A.N., Susulic,V.S., Madura,J.P., Zhang,B., Moller,D.E., Tontonoz,P., Sarraf,P., Spiegelman,B.M. and Lowell,B.B. (1997) Functional antagonism between CCAAT/enhancer binding protein-α and peroxisome proliferator-activated receptor-γ on the leptin promoter. J. Biol. Chem., 21, 5283-5290.
15. Lehmann,J.M., Moore,L.B., Smith-Oliver,T.A., Wilkison,W.O., Willson,T.M. and Kliewer,S.A. (1995) An antidiabetic thiazolidinedione is a higher affinity ligand for peroxisome proliferator-activated receptor γ. J. Biol. Chem., 270, 12953-12956.
16. Fajas,L., Auboeuf,D., Raspe,E., Schoonjans,K., Lefebvre,A.M., Saladin,R., Najib,J., Laville,M., Fruchart,J.C., Deeb,S., Puig-Vidal,A., Flier,J., Briggs,M.R., Staels,B., Vidal,H. and Auwerx,J. (1997) The human PPARγ gene: organization, promoter analysis, and expression. J. Biol. Chem., 272, 18779-18789.
17. Zhang,Y., Proenca,R., Maffei,M., Barone,M., Leopold,L. and Friedman,J.M. (1994) Positional cloning of the mouse obese gene and its human homolog. Nature, 372, 425-432.
18. Tartaglia,L.A., Dembski,M., Weng,X., Deng,N., Culpepper,J., Devos,R., Richards,G.J., Campfield,L.A., Clark,F.T., Deeds,J., Muir,C., Sankers,S., Moriarty,A., Moore,K.J., Smuiko,J.S., May,G.G., Woolf,E.A., Monroe,C.A. and Tepper,R.I. (1995) Identification and expression cloning of a leptin receptor, Ob-R. Cell, 83, 1263-1271.
19. Maffei,M., Halaas,J.L., Ravussin,E., Pratley,R.E., Lee,G.H., Zhang,Y., Fei,H., Kim,S., Lallone,R., Ranganathan,S., Kern,P.A. and Friedman,J.M. (1995) Leptin levels in human and rodent: measurement of plasma leptin and ob RNA in obese and weight-reduced subjects. Nature Med., 1, 1155-1161.
20. Lonnqvist,F., Amer,P., Nordfors,L. and Schalling,M. (1995) Overexpression of the obese (ob) gene in adipose tissue of human obese subjects. Nature Med., 1, 953-956.
21. Ma,Z., Gingerich,R.L., Santiago,J.V., Klain,S. and Smith,C.H. (1996) Radioimmunoassay of leptin in human plasma. Clin. Chem., 42, 942-946.
22. Considine,R.V., Sinha,M.K., Heiman,M.L., Kriauciunas,A., Stephens,T.W., Nyce,M.R., Ohannesian,J.P., Marco,C.C., McKee,L.J., Bauer,T.L. and Caro,J.F. (1996) Serum immunoreactive-leptin concentrations in normal-weight and obese humans. N. Engl. J. Med., 334, 292-295.
23. WHO (1997) Prevention and Management of the Global Epidemic of Obesity. Report of the WHO Consultation on Obesity. WHO, Geneva, Press Release WHO/46; 12 June 1997.
24. Moll,P.P., Burns,T.L. and Lauer,R.M. (1991) The genetic and environmental sources of body mass index variability: the Muscatine ponderosity family study. Am. J. Hum. Genet., 49, 1243-1255.
25. Price,R.A. and Gottesman,I.I. (1991) Body fat in identical twins reared apart: roles for genes and environment. Behav. genet., 21, 1-7.
26. Fumeron,F., Rigaud,D., Bertier,N.C., Bardon,S., Dely,S. and Apfelbaum,M. (1988) Association of apolipoprotein E ε4 allele with hypertriglyceridemia in obesity. Clin. Genet., 34, 258-264.
27. Comuzzie,A.G., Hixson,J.E., Almasy,L., Mitchell,B.D., Mahaney,M.C., Dyer,T.D., Stern,M.P., MacCluer,J.W. and Blangero,J. (1997) A major quantitative trait locus determining serum leptin levels and fat mass is located on human chromosome 2. Nature Genet., 15, 273-276.
28. Nolan,J.J., Olefsky,J.M., Nyce,M.R., Considine,R.V. and Caro,J.F. (1996) Effect of troglitazone on leptin production. Studies in vitro and in human subjects. Diabetes, 45, 1276-1278.
29. Tunstall-Pedoe,H., Kuulasmaa,K., Amouyel,P., Arveiler,D., Rajakangas,A.M., Pajak,A. on behalf of the WHO MONICA Project (1994) Myocardial infarction and coronary deaths in the World Health Organization MONICA Project. Registration procedures, even rates and case fatality in 38 populations from 21 countries in 4 continents. Circulation, 90, 583-612.
30. The World Health Organization MONICA Project (1994) Ecological analysis of the association between mortality and major risks factors of cardiovascular disease. Int. J. Epidemiol., 23, 505-516.
31. Marcadet,A., O'Connell,P. and Cohen,D. (1987) Standardized Southern blot workshop technique. In Dupont,B. (ed), Histocompatibility Testing. Springer, New York, NY, Vol. 1, pp. 553-560.